ATE310746T1 - Leishmanien antigene für die verwendung in der therapie und diagnose von leishmaniose - Google Patents

Leishmanien antigene für die verwendung in der therapie und diagnose von leishmaniose

Info

Publication number
ATE310746T1
ATE310746T1 AT01928377T AT01928377T ATE310746T1 AT E310746 T1 ATE310746 T1 AT E310746T1 AT 01928377 T AT01928377 T AT 01928377T AT 01928377 T AT01928377 T AT 01928377T AT E310746 T1 ATE310746 T1 AT E310746T1
Authority
AT
Austria
Prior art keywords
leishmaniasis
diagnosis
therapy
leishmania antigens
leishmania
Prior art date
Application number
AT01928377T
Other languages
English (en)
Inventor
Steven G Reed
Antonio Campos-Neto
John R Webb
Davin C Dillon
Yasir A W Skeiky
Ajay Bhatia
Rhea M Coler
Peter Probst
Original Assignee
Corixa Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/551,974 external-priority patent/US6500437B1/en
Priority claimed from US09/565,501 external-priority patent/US6607731B1/en
Application filed by Corixa Corp filed Critical Corixa Corp
Application granted granted Critical
Publication of ATE310746T1 publication Critical patent/ATE310746T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
AT01928377T 2000-04-14 2001-04-05 Leishmanien antigene für die verwendung in der therapie und diagnose von leishmaniose ATE310746T1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US09/551,974 US6500437B1 (en) 1995-09-22 2000-04-14 Leishmania antigens for use in the therapy and diagnosis of leishmaniasis
US09/565,501 US6607731B1 (en) 1995-09-22 2000-05-05 Leishmania antigens for use in the therapy and diagnosis of leishmaniasis
US09/639,206 US6613337B1 (en) 1997-02-12 2000-08-14 Leishmania antigens for use in the therapy and diagnosis of leishmaniasis
PCT/US2001/011254 WO2001079276A2 (en) 2000-04-14 2001-04-05 Leishmania antigens for use in the therapy and diagnosis of leishmaniasis

Publications (1)

Publication Number Publication Date
ATE310746T1 true ATE310746T1 (de) 2005-12-15

Family

ID=27415636

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01928377T ATE310746T1 (de) 2000-04-14 2001-04-05 Leishmanien antigene für die verwendung in der therapie und diagnose von leishmaniose

Country Status (10)

Country Link
US (1) US6613337B1 (de)
EP (2) EP1681301B1 (de)
AR (1) AR028333A1 (de)
AT (1) ATE310746T1 (de)
AU (1) AU2001255241A1 (de)
DE (1) DE60115230T2 (de)
ES (2) ES2255553T3 (de)
MX (1) MXPA02010173A (de)
PT (1) PT1681301E (de)
WO (1) WO2001079276A2 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ID30407A (id) 1999-05-13 2001-11-29 American Cyanamid Co Formulasi-formulasi kombinasi bahan penambah
EP1255562B1 (de) * 2000-02-18 2008-01-16 Vlaams Interuniversitair Instituut voor Biotechnologie vzw. Gebrauch von opri lipoprotein aus pseudomonas als th1 induzierendes natürliches adjuvans für heterologe antigene
WO2002038177A2 (en) * 2000-11-10 2002-05-16 Wyeth Holdings Corporation Adjuvant combination formulations
US7833534B2 (en) 2006-04-10 2010-11-16 Infectious Disease Research Institute Compounds and methods for diagnosis and treatment of leishmaniasis
US8916168B2 (en) 2007-07-13 2014-12-23 Infectious Disease Research Institute Leishmania sterol 24-c-methyltransferase compositions for the prevention, treatment and diagnosis of leishmaniasis
US8410258B2 (en) 2008-05-21 2013-04-02 Infections Disease Research Institute Recombinant polyprotein vaccines for the treatment and diagnosis of leishmaniasis
US8425919B2 (en) 2008-05-21 2013-04-23 Infectious Disease Research Institute Recombinant polyprotein vaccines for the treatment and diagnosis of leishmaniasis
BRPI0913972B1 (pt) 2008-07-03 2018-06-26 Infectious Disease Research Institute Polipeptídeo de fusão compreendendo antígenos de leishmania, polinucleotídeo, composição farmacêutica, bem como métodos para detecção de infecção e para identificação de leishmaniose e kit diagnóstico para detecção e identificação de leishmaniose
BRPI0900961B8 (pt) * 2009-03-23 2021-07-13 Fundacao Oswaldo Cruz métodos e kit para diagnóstico de leishmaniose
AP3516A (en) 2009-07-13 2016-01-11 Leti Sl Lab Diagnosis of a parasitic disease such as leishmaniasis using ribosomal protein extract (rpe)
WO2014091463A1 (pt) * 2012-12-14 2014-06-19 Universidade Federal De Minas Gerais - Ufmg Processo para produção de proteínas recombinantes de leishmania e uso em kit para diagnóstico e vacina contra leishmanioses
EP2978447B1 (de) 2013-03-28 2019-05-08 Infectious Disease Research Institute Impfstoffe mit leishmania-polypeptiden zur behandlung und diagnose von leishmaniase
US20140356391A1 (en) * 2013-05-29 2014-12-04 Jose Antonio O'Daly Amino acid sequences for clinical remission of psoriasis and related diseases.
JP2016053535A (ja) * 2014-09-04 2016-04-14 国立大学法人 東京大学 皮膚型リーシュマニア症の検査用試薬又はキット、及び皮膚型リーシュマニア症の検査方法

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4870006A (en) 1986-07-24 1989-09-26 Codon Antigenic material for a chagas' disease detection system
US5411865A (en) 1993-01-15 1995-05-02 Iasys Corporation Method of detecting anti-leishmania parasite antibodies
US5961970A (en) 1993-10-29 1999-10-05 Pharmos Corporation Submicron emulsions as vaccine adjuvants
US5571515A (en) 1994-04-18 1996-11-05 The Wistar Institute Of Anatomy & Biology Compositions and methods for use of IL-12 as an adjuvant
US5879687A (en) 1994-04-22 1999-03-09 Corixa Corporation Methods for enhancement of protective immune responses
US6013268A (en) 1994-04-22 2000-01-11 Corixa Corporation Methods for enhancement of protective immune responses
US5876735A (en) 1994-04-22 1999-03-02 Corixa Corporation Methods for enhancement of protective immune responses
BR9507505A (pt) 1994-04-22 1997-09-02 Corixa Corp Molécula de dna isolada vetor de expressão recombinante célula hospedeira método para preparar um polipeptídeo que estimula uma resposta imunológica th1 em células mononucleares do sangue periférico obtidas a partir de um individuo infectado com leishmania polipeptídeo método para avaliar a capacidade de um paciente de gerar uma resposta imunológica método para melhorar uma resposta imunológica celular e/ou humoral a um antígeno de um paciente método para estimular a produção de anticorpos em um
US5912166A (en) 1995-04-21 1999-06-15 Corixa Corporation Compounds and methods for diagnosis of leishmaniasis
US5965142A (en) 1995-08-04 1999-10-12 Corixa Corporation Polypeptides and methods for the detection of L. tropica infection
US5834592A (en) 1995-09-22 1998-11-10 Corixa Corporation Leishmania antigens for use in the therapy and diagnosis of Leishmaniasis
US5744593A (en) * 1996-02-15 1998-04-28 Heska Corporation Parasitic helminth larval thiol specific antioxidant proteins and nucleic acid molecules
US5910306A (en) 1996-11-14 1999-06-08 The United States Of America As Represented By The Secretary Of The Army Transdermal delivery system for antigen
US5980898A (en) 1996-11-14 1999-11-09 The United States Of America As Represented By The U.S. Army Medical Research & Material Command Adjuvant for transcutaneous immunization
US5846748A (en) 1996-11-15 1998-12-08 The Council Of Scientific & Industrial Research Method for diagnosing visceral leishmaniasis in a patient by identification of a new key marker namely 9-O-acetylated sialoglycoconjugate
EP2284186A1 (de) 1997-02-12 2011-02-16 Corixa Corporation Leishmanien-Antigene zur Verwendung bei der Therapie und Diagnose von Leishmaniose
WO2000039298A1 (en) * 1998-12-23 2000-07-06 C.B.F. Leti S.A. Chimeric gene encoding the antigenic determinants of four proteins of l. infantum

Also Published As

Publication number Publication date
US6613337B1 (en) 2003-09-02
MXPA02010173A (es) 2003-06-04
EP1681301B1 (de) 2012-07-18
EP1681301A1 (de) 2006-07-19
AU2001255241A1 (en) 2001-10-30
PT1681301E (pt) 2012-10-26
WO2001079276A3 (en) 2002-09-06
ES2391562T3 (es) 2012-11-27
EP1287026B1 (de) 2005-11-23
DE60115230T2 (de) 2006-08-03
ES2255553T3 (es) 2006-07-01
WO2001079276A2 (en) 2001-10-25
AR028333A1 (es) 2003-05-07
DE60115230D1 (de) 2005-12-29
EP1287026A2 (de) 2003-03-05

Similar Documents

Publication Publication Date Title
DE3577185D1 (de) Paramagnetische kontrastmittel fuer die anwendung in "in vivo" nmr-diagnostischen methoden und die herstellung davon.
DE59507780D1 (de) Bürste für die Zahn- und Körperpflege
DE59603216D1 (de) Esterquats und ihre Verwendung zur Herstellung von oberflächenaktiven Mitteln, insbesondere zur Haar- und Körperpflege
DE60223547D1 (de) Gangliosid-assoziierte rekombinante antikörper und deren verwendung bei der diagnose und behandlung von tumoren
DE69529245D1 (de) Nicht-invasiver Blutanalysator
DE69811114D1 (de) Tampon für die frauenhygiene oder medizinische zwecke und verfahren zur herstellung desselben
DE60115230D1 (de) Leishmanien antigene für die verwendung in der therapie und diagnose von leishmaniose
DE69435088D1 (de) Therapeutische und diagnostische mittel für die amyloidosis
DE69819996D1 (de) Gerät für die Zählung von Blutzellen und zur immunologischen Bestimmung unter Verwendung von Vollblut
DE69942614D1 (de) Vorrichtung zur diagnose und therapie von elektrophysiologischen krankheiten
DE60036077D1 (de) Katalysatorherstellung und verwendung für die acrylsäureherstellung
FR2766192B1 (fr) Epitopes du vrs et anticorps les comportant, utiles dans le diagnostic et la therapie
ATE337335T1 (de) Oberflächenantigene und proteine für zusammensetzungen zu diagnose und vorbeugung der lyme-kkrankheit
DE69737870D1 (de) Medikamente für die diagnostik von autoimmunerkrankungen
ID27576A (id) Penggunaan siklosporin dalam pengobatan penyakit-penyakit peradangan autoimun
ATE311417T1 (de) Schlichtemittel für glasorgane, verwendungsverfahren und produkte daraus
ATE282400T1 (de) Oxidationszusammensetzung und verwendungen derselben für die behandlung von keratinischen fasern
EP1313753A4 (de) Regulatorgene und für die diagnose und therapie der osteoporose brauchbares system
DE60134267D1 (de) Prophylaktische/therapeutische mittel für entzündliche atemwegserkrankungen
DE69915113D1 (de) 5ht1 rezeptor antagonisten und ihre verwendung für die behandlung von depression
EP1448056A4 (de) Surfactant-protein d für die vorbeugung und diagnose von lungenemphysem
DE69927016D1 (de) Durchscheinendes reinigungsstück für die körperpflege
EP0759976A4 (de) Die isolierung und herstellung von katalytischen antikörpern mittels phagentechnologie
AU2002305811A1 (en) Leishmania antigens for use in the therapy and diagnosis of leishmaniasis
PL336978A1 (en) Strip-type test for performing an allergy diagnosis in vitro

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties